FURIAN, LUCREZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.614
AS - Asia 3.215
EU - Europa 2.547
AF - Africa 920
SA - Sud America 838
OC - Oceania 101
Continente sconosciuto - Info sul continente non disponibili 52
Totale 17.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.118
SG - Singapore 930
CN - Cina 625
BR - Brasile 529
IT - Italia 476
HK - Hong Kong 470
DE - Germania 290
FI - Finlandia 269
VN - Vietnam 180
PL - Polonia 164
FR - Francia 119
SE - Svezia 115
GB - Regno Unito 111
RU - Federazione Russa 111
UA - Ucraina 109
NL - Olanda 77
IN - India 76
TR - Turchia 55
AT - Austria 53
KR - Corea 50
MX - Messico 49
AR - Argentina 48
ES - Italia 47
IE - Irlanda 47
JP - Giappone 45
KE - Kenya 40
CA - Canada 39
IQ - Iraq 39
MY - Malesia 39
NP - Nepal 39
AZ - Azerbaigian 38
EC - Ecuador 37
PH - Filippine 37
UZ - Uzbekistan 37
CI - Costa d'Avorio 36
PA - Panama 35
LY - Libia 34
SA - Arabia Saudita 34
VE - Venezuela 34
BS - Bahamas 33
KG - Kirghizistan 31
PY - Paraguay 31
ZA - Sudafrica 31
CL - Cile 30
DK - Danimarca 30
GH - Ghana 30
PK - Pakistan 30
TZ - Tanzania 30
UY - Uruguay 30
MA - Marocco 29
RO - Romania 29
TT - Trinidad e Tobago 29
NI - Nicaragua 28
CR - Costa Rica 27
CZ - Repubblica Ceca 27
EG - Egitto 27
HU - Ungheria 27
JM - Giamaica 27
PE - Perù 27
SN - Senegal 27
BF - Burkina Faso 26
BY - Bielorussia 26
CO - Colombia 26
CW - ???statistics.table.value.countryCode.CW??? 26
CY - Cipro 26
GM - Gambi 26
IL - Israele 26
ME - Montenegro 26
PT - Portogallo 26
AE - Emirati Arabi Uniti 25
AU - Australia 25
CH - Svizzera 25
IR - Iran 25
LC - Santa Lucia 25
TN - Tunisia 25
GA - Gabon 24
GN - Guinea 24
IS - Islanda 24
JO - Giordania 24
KZ - Kazakistan 24
LA - Repubblica Popolare Democratica del Laos 24
MK - Macedonia 24
XK - ???statistics.table.value.countryCode.XK??? 24
YT - Mayotte 24
BJ - Benin 23
BO - Bolivia 23
CV - Capo Verde 23
DO - Repubblica Dominicana 23
LB - Libano 23
LV - Lettonia 23
NO - Norvegia 23
SD - Sudan 23
SK - Slovacchia (Repubblica Slovacca) 23
SO - Somalia 23
AO - Angola 22
BE - Belgio 22
CU - Cuba 22
GF - Guiana Francese 22
ID - Indonesia 22
ML - Mali 22
Totale 16.253
Salva come PNG Salva come JPEG
Città #
Fairfield 1.279
Ashburn 867
Woodbridge 857
Houston 700
Chandler 639
Ann Arbor 616
Singapore 569
Seattle 456
Cambridge 447
Hong Kong 447
Wilmington 426
Jacksonville 396
Boardman 211
Beijing 200
Princeton 172
San Diego 170
Santa Clara 143
Des Moines 135
Bytom 126
Munich 110
Helsinki 109
Medford 100
Padova 95
Dong Ket 90
Nanjing 70
Los Angeles 56
Roxbury 53
São Paulo 51
New York 49
Chicago 48
Hefei 44
Dublin 43
Baku 35
Turku 35
Abidjan 34
Nuremberg 34
Tashkent 32
Panama City 31
Ho Chi Minh City 30
London 30
Nairobi 30
Nassau 30
Shenyang 30
Vienna 30
Buffalo 29
Rome 29
Bishkek 27
Dakar 27
Managua 27
Seoul 27
Milan 26
Montevideo 26
Rio de Janeiro 26
Accra 25
Castries 25
Conakry 24
Hanoi 24
Warsaw 24
Amman 23
Lappeenranta 23
Libreville 23
Willemstad 23
Bamako 22
Cotonou 22
Dar es Salaam 22
Kingston 22
Tokyo 22
San José 21
Changsha 20
Guangzhou 20
Havana 20
Kampala 20
Ouagadougou 20
Phnom Penh 20
Praia 20
Reykjavik 20
Andorra la Vella 19
Antananarivo 19
Noumea 19
Podgorica 19
Riga 19
Tripoli 19
Ulan Bator 19
Bridgetown 18
Mamoudzou 18
Ogden 18
Kigali 17
Kingstown 17
Lima 17
Luanda 17
Lusaka 17
Pristina 17
Vientiane 17
Dallas 16
Falls Church 16
Harare 16
Istanbul 16
Jiaxing 16
Kuala Lumpur 16
Nanchang 16
Totale 11.322
Salva come PNG Salva come JPEG
Nome #
Deceased donor-initiated Chains: first report of a successful deliberate case and its ethical implications 245
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients. 242
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 223
Use of Eculizumab for Rescue Therapy of a Severe Antibody-Mediated Rejection in a Living Kidney Transplant 212
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 212
Balance impairment in kidney transplant recipients without concurrent peripheral neuropathy 211
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors 210
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5) 180
Early activation of fibrogenesis in transplanted kidneys: a study on serial renalbiopsies 180
Does taking part in multiple clinical studies with new immunosuppressive agents affect the outcome of renal transplantation? 178
Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies 177
Refinement of a macaque transplantation model: application of a subcutaneous port as a means for long-term enteral drug administration and nutritional supplementation. 176
Postural balance, muscle strength, and history of falls in end-stage renal disease patients living with a kidney transplant: A cross-sectional study 176
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression 175
Coadministration of sirolimus alters tacrolimus pharmacokinetics. 173
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. 168
Short-term outcome of dual kidney transplantation at a single center 166
Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study 165
Swine pancreas preservation with Celsior solution 164
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity 162
Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients 162
Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy. 158
Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation 157
A single-center experience with 200 dual kidney transplantations. 157
Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation 157
Glomerulitis and endothelial cell enlargement in C4d(+) and C4d(-) acute rejections of renal transplant patients. 155
Application of cyclosporine in renal transplantation: experience at the University of Padua 152
C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients:single-center incidence and outcome. 151
Pancreas Preservation With Celsior Solution in a Pig Autotransplantation Model: Comparative Study With University of Wisconsin Solution 150
Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. 149
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study) 148
Combined liver–dual kidney transplant: Role in expanded donors 148
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 147
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation 146
Combined liver and kidney transplantation: analysis of Padova experience. 145
Hepatitis C virus infection in end stage renal disease and kidney transplantation 143
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 143
How does age affect the outcome of kidney transplantation in elderly recipients? 143
Acute rejection and graft survival in renal transplanted patients with viral diseases 142
Excellent Performance of Kidneys from Octogenarian Donors Transplanted as Dual Kidney Transplantation 142
The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities 141
Laparoscopic live donor nephrectomy: Single center experience 139
Lower Urinary Tract Symptoms in Kidney Transplant Recipients and Timing of Treatment With TURP: Impact on Renal Graft Survival and Function 138
Monolateral placement of both kidneys in dual kidney transplantation: low surgical complication rate and short operating time 137
Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation 134
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 134
Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation 133
Technical Aspects of Unilateral Dual Kidney Transplantation from Expanded Criteria Donors: Experience of 100 Patients 133
Plasma fibrinolytic capacity in renal transplant recipients: Effect of steroid-free immunosuppression therapy. 132
Ipsilateral placement in double-kidney transplantation: An old technique in a new fashion 131
Kidney exchange strategies: new aspects and applications with a focus on deceased donor-initiated chains 131
Mumps-associated nephritis mimicking acute rejection in a patient under chronic dialysis treatment because of graft dysfunction 129
Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia. 129
Therapeutic apheresis in kidney AB0 incompatible transplantation 129
Overshoot of the respiratory exchange ratio during recovery from maximal exercise testing in kidney transplant recipients 129
Transplantation: Optimizing outcomes in elderly kidney transplant recipients. 128
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 127
COVID-19 and kidney transplantation: an Italian Survey and Consensus 126
Celsior (R), a new organ preservation solution, in kidney and pancreas experimental transplantation. 125
ADVANTAGES OF PSI plus LOW-DOSE CNI VS PSI ALONE IN DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS 121
Everolimus Associated With Low-Dose Calcineurin Inhibitors, an Option in Kidney Transplant Recipients of Very Old Donors 121
Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study 120
Deuterium nuclear magnetic resonance for evaluating the metabolic status of livers subjected to warm ischemia 118
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 117
Outcome of Renal Transplantation from Very Old Donors 115
Administration of a fluid diet as a means for nutritional supplementation in challinging experimantal primate model 115
Early activation of fibrogenesis in transplanted kidney. A study on serial biopsies. 114
Acute rejection features in dual kidney transplant recipients fromelderly donors: comparison of calcineurin inhibitor-based and calcineurininhibitor-free immunosuppressive protocols. 114
Renal Transplantation: What Has Changed in Recent Years 114
Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial 114
Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis. 113
Calcineurin inhibitor-free immunosuppression in dual kidney transplantation from elderly donors 112
Histological markers of humoral rejection in renal transplant patients. 108
CYCLOSPORIN A AND TACROLIMUS, COMBINED WITH MYCOPHENOLIC ACID, ARE EQUALLY EFFECTIVE IN PREVENTING THE ONSET OF DE NOVO ANTI-HLA ANTIBODIES 106
Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS 105
Refinement of a primate xenotransplantation model: application of a subcutaneously implanted port as a means of gastric nutrition 103
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 103
Chronic allograft nephropathy in renal transplanted patients experiencing acute rejection episodes 102
PROLIFERATION SIGNAL INHIBITORS (PSI) CAN BE SAFELY USED AB INITIO AFTER DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS (ED) 101
Implementation of the 3 R's Tenet to primate research: application of a new device as a means of long-term enteral administration of drugs or nutritional supplementation 100
Surgical complications in simultaneous pancreas and kidney transplantation (SPK) with enteric exocrine drainage and systemic venous drainage 99
null 98
Optimizing Allocation of Kidneys from Older Donors: Between Resources and Results 96
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 96
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 95
Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. 95
Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. 95
Anti-HCV positive patients with end stage renal disease (ESRD): assessment of liver disease before and after kidney transplantation (KT) 94
Kidney Donation after circulatory death: The Veneto Region experience in Italy 92
Organ Donors with Small Renal Cancer: Report of 3 Cases 92
DNA Methylation - and Telomere - Based Biological Age Estimation as Markers of Biological Aging in Donors Kidneys 91
How Long Does It Take to Acquire Mastery of Performance in Laparoscopic Living Donor Nephrectomy? A Center-Based and Surgeon-Based Operative Time CUSUM Analysis 90
ROTEM (R) thromboelastometry in primate recipients of porcine kidneys. 89
Implementation of the three R's Tenet to primate research: application of a new device as a means of long-term enteral administration of drugs or nutritional supplementation 89
Using deceased-donor kidneys to initiate chains of living donor kidney paired donations: algorithm and experimentation 89
Digital pathology for second opinion consultation and donor assessment during organ procurement: Review of the literature and guidance for deployment in transplant practice 89
First World Consensus Conference on pancreas transplantation: Part II – recommendations 89
Circulating microparticles plasma levels in primates recipients of hDAF and GalT-KO pig kidney 88
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 87
Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience 87
Totale 13.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.746
article - articoli 57.158
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 252
Totale 117.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.326 0 0 0 89 156 108 98 124 191 163 177 220
2021/20221.719 44 166 214 136 70 138 112 185 65 53 189 347
2022/20231.380 277 141 16 167 202 246 3 80 146 24 61 17
2023/2024831 23 90 88 62 80 75 63 95 38 27 107 83
2024/20253.300 23 178 154 121 396 92 179 216 283 138 580 940
2025/20264.624 604 1.103 1.868 1.049 0 0 0 0 0 0 0 0
Totale 17.433